|
Category | FY | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
Pneumonia
|
2014
|
NIAAA
|
5P60AA009803-21
|
5161
|
Research Component 3
|
KOLLS, JAY
|
LOUISIANA STATE UNIV-UNIV OF NEW ORLEANS
|
LA
|
$124,571
|
Pneumonia
|
2014
|
NIAID
|
5R01AI097434-03
|
|
Role of Staphylococcus aureus alpha-hemolysin in disease
|
BUBECK WARDENBURG, JULIANE
|
UNIVERSITY OF CHICAGO
|
IL
|
$390,000
|
Pneumonia
|
2014
|
NIEHS
|
5R03ES022378-02
|
|
Obesity and Environmental Lung Disease: The Role of Chemerin
|
JOHNSTON, RICHARD
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$75,240
|
Pneumonia
|
2014
|
NIAID
|
5R01AI027913-25
|
|
Bioactivities of Pneumococcal Cell Wall in Meningitis
|
TUOMANEN, ELAINE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$420,000
|
Pneumonia
|
2014
|
NIAID
|
5R01AI050083-10
|
|
The Cell Biology of Coronavirus Infection
|
DENISON, MARK
|
VANDERBILT UNIVERSITY
|
TN
|
$347,490
|
Pneumonia
|
2014
|
NIAID
|
5R01AI090060-04
|
|
Messenger RNA Capping and Methylation in Pneumoviruses
|
LI, JIANRONG
|
OHIO STATE UNIVERSITY
|
OH
|
$381,250
|
Pneumonia
|
2014
|
NIAID
|
5R43AI104046-02
|
|
Aminoglycoside potentiators for P. aeruginosa therapy
|
MOIR, DONALD
|
MICROBIOTIX, INC
|
MA
|
$300,000
|
Pneumonia
|
2014
|
NIAID
|
5R01AI097172-03
|
|
Sinusitis in Children and the Nasopharyngeal Microbiome
|
WALD, ELLEN
|
UNIVERSITY OF WISCONSIN-MADISON
|
WI
|
$718,967
|
Pneumonia
|
2014
|
NIAID
|
5R01AI015608-33
|
|
Cytotoxic T Lymphocyte Response to Influenza Virus
|
BRACIALE, THOMAS
|
UNIVERSITY OF VIRGINIA
|
VA
|
$453,500
|
Pneumonia
|
2014
|
NIAID
|
5F31AI104298-02
|
|
Impact of glycosylation on PsrP function
|
LIZCANO, ANEL
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
TX
|
$13,192
|
Pneumonia
|
2014
|
NHLBI
|
5R37HL079142-10
|
|
Th17 Cytokines and Lung Immunity
|
KOLLS, JAY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$507,666
|
Pneumonia
|
2014
|
NHLBI
|
5R01HL107380-03
|
|
Influenza A Inhibits TH17 Host Defense Against Bacterial Pneumonia
|
ALCORN, JOHN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$365,119
|
Pneumonia
|
2014
|
NHLBI
|
5R01HL093022-05
|
|
E-cadherin shedding in chronic lung injury
|
MCGUIRE, JOHN
|
UNIVERSITY OF WASHINGTON
|
WA
|
$402,633
|
Pneumonia
|
2014
|
NHLBI
|
5P01HL092870-05
|
6708
|
Genetic basis of Pulmonary Fibrosis
|
PHILLIPS, JOHN
|
VANDERBILT UNIVERSITY
|
TN
|
$320,961
|
Pneumonia
|
2014
|
NIAID
|
5R01AI100913-02
|
|
Bacterial inhibitors of eukaryotic membrane fusion
|
STARAI, VINCENT
|
UNIVERSITY OF GEORGIA
|
GA
|
$334,125
|
Pneumonia
|
2014
|
NIAID
|
5R03AI103294-02
|
|
Zinc-binding lipoproteins of S. pneumoniae regulate invasiveness
|
THORNTON, JUSTIN
|
MISSISSIPPI STATE UNIVERSITY
|
MS
|
$72,250
|
Pneumonia
|
2014
|
NIAID
|
5R43AI104029-02
|
|
Rapid, automated, detection of viral and bacterial pathogens causing meningitis
|
HEMMERT, ANDREW
|
BIOFIRE DIAGNOSTICS, INC.
|
UT
|
$152,630
|
Pneumonia
|
2014
|
NIAID
|
5R44AI091267-04
|
|
A CD8+ T cell diagnostic to identify children with pulmonary tuberculosis
|
NYENDAK, MELISSA
|
VITI, INC.
|
OR
|
$996,814
|
Pneumonia
|
2014
|
NIAID
|
5R01AI088100-04
|
|
A role of osteopontin in innate immunity against fungal infection
|
SHINOHARA, MARI
|
DUKE UNIVERSITY
|
NC
|
$389,815
|
Pneumonia
|
2014
|
NIAID
|
5R01AI095338-03
|
|
The Role of Hepoxilin A3 in Neutrophil Breach of the Infected Airway Mucosa
|
HURLEY, BRYAN
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$439,285
|
Pneumonia
|
2014
|
NIAID
|
7R01AI095740-03
|
|
Mechanisms of Haemophilus influenzae pathogenesis in the lung
|
AKERLEY, BRIAN
|
UNIVERSITY OF MISSISSIPPI MED CTR
|
MS
|
$392,253
|
Pneumonia
|
2014
|
NIGMS
|
5R01GM100784-03
|
|
Mechanisms of risk for sulfoniamide hypersensitivity
|
TREPANIER, LAUREN
|
UNIVERSITY OF WISCONSIN-MADISON
|
WI
|
$298,309
|
Pneumonia
|
2014
|
NIAID
|
5R44AI092904-03
|
|
Rapidly boosting innate immunity in the lungs to protect against pneumonia
|
SCOTT, BRENTON
|
PULMOTECT, INC
|
TX
|
$308,146
|
Pneumonia
|
2014
|
NIAID
|
5R21AI103328-02
|
|
Targeting a leukocyte disintegrin metalloprotease during bacterial pneumonia
|
WALCHECK, BRUCE
|
UNIVERSITY OF MINNESOTA
|
MN
|
$228,000
|
Pneumonia
|
2014
|
NHLBI
|
5R01HL115778-02
|
|
Plasma Gelsolin and Host Defense After Lung Injury
|
KOBZIK, LESTER
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
MA
|
$395,675
|
Pneumonia
|
2014
|
NIAID
|
5R01AI093727-04
|
|
Role of the Plasminogen Activator Protease during Pneumonic Plague
|
LATHEM, WYNDHAM
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$381,250
|
Pneumonia
|
2014
|
NIAID
|
5R01AI098458-03
|
|
Pneumocystis jirovecii Targeted Antiopportunistic Agents
|
GANGJEE, ALEEM
|
DUQUESNE UNIVERSITY
|
PA
|
$380,747
|
Pneumonia
|
2014
|
NIAID
|
5K23AI104779-02
|
|
Development and Validation of a Clinical Prediction Rule for Pediatric Pneumonia
|
WILLIAMS, DEREK
|
VANDERBILT UNIVERSITY
|
TN
|
$172,098
|
Pneumonia
|
2014
|
NHLBI
|
5R01HL116472-02
|
|
Regulation of Innate Immunity by F-Box Proteins
|
CHEN, BEIBEI
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$375,769
|
Pneumonia
|
2014
|
NIDDK
|
5R01DK047814-20
|
|
X-ray Studies of Sugar-Modifying Enzymes
|
HOLDEN, HAZEL
|
UNIVERSITY OF WISCONSIN-MADISON
|
WI
|
$316,236
|
Pneumonia
|
2014
|
NHLBI
|
5F30HL107092-04
|
|
Phagocyte Intoxication by ExoU in Pseudomonas Pneumonia
|
ZHANG, ANGELICA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$45,418
|
Pneumonia
|
2014
|
NIEHS
|
5F32ES022582-02
|
|
Effects of Traffic Pollution on Lung Immunity and Pneumonia in Persons with HIV
|
BLOUNT, ROBERT
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$67,622
|
Pneumonia
|
2014
|
NIAID
|
5R01AI090155-05
|
|
The molecular basis of the epidemic blaKPC gene Klebsiella
|
KREISWIRTH, BARRY
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
NJ
|
$564,497
|
Pneumonia
|
2014
|
NIAID
|
5R01AI101285-02
|
|
Coordinate regulation of competence and pneumocin production in S. pneumoniae
|
DAWID, SUZANNE
|
UNIVERSITY OF MICHIGAN
|
MI
|
$382,742
|
Pneumonia
|
2014
|
NIAID
|
5R01AI104711-02
|
|
Structure and Mechanism of Programmed Ribosomal Frameshifting in SARS coronavirus
|
D'SOUZA, VICTORIA
|
HARVARD UNIVERSITY
|
MA
|
$380,250
|
Pneumonia
|
2014
|
NIAID
|
1R01AI104841-01A1
|
|
Propargyl-linked Antifolates Targeting Klebsiella pneumoniae
|
ANDERSON, AMY
|
UNIVERSITY OF CONNECTICUT STORRS
|
CT
|
$562,189
|
Pneumonia
|
2014
|
NIAID
|
5K02AI085403-05
|
|
Modulation of Host Vesicle Trafficking by Legionella pneumophila
|
LUO, ZHAO-QING
|
PURDUE UNIVERSITY
|
IN
|
$111,201
|
Pneumonia
|
2014
|
NIAID
|
5R01AI099107-03
|
|
Analysis of Coronavirus-Host Cell Interactions
|
MAKINO, SHINJI
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$382,500
|
Pneumonia
|
2014
|
NIA
|
2P01AG027296-06A1
|
5771
|
STUDY OF HOSPITALS STAFFING ATTENDING PHYSICIAN ROLE FOR PATIENTS AT END OF LIFE
|
TENO, JOAN
|
BROWN UNIVERSITY
|
RI
|
$238,573
|
Pneumonia
|
2014
|
NIAID
|
1R21AI109094-01
|
|
Critical neutralizing domain-based vaccines against new SARS-like virus hCoV-EMC
|
DU, LANYING
|
NEW YORK BLOOD CENTER
|
NY
|
$212,167
|
Pneumonia
|
2014
|
NHLBI
|
1R01HL117976-01A1
|
|
Epithelial mechanisms of inducible resistance to AML-associated pneumonia
|
EVANS, SCOTT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
TX
|
$400,000
|
Pneumonia
|
2014
|
NIAID
|
1R01AI105013-01A1
|
|
Control of fimbrial gene expression in Pseudomonas aeruginosa
|
DOVE, SIMON
|
CHILDREN'S HOSPITAL CORPORATION
|
MA
|
$437,917
|
Pneumonia
|
2014
|
NIGMS
|
5R01GM061050-11
|
|
Structural Studies of Paramyxovirus fusion proteins
|
JARDETZKY, THEODORE
|
STANFORD UNIVERSITY
|
CA
|
$301,440
|
Pneumonia
|
2014
|
NIAID
|
1R01AI105168-01A1
|
|
Early Events in Pneumococcal Colonization
|
WEISER, JEFFREY
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$394,742
|
Pneumonia
|
2014
|
NIAID
|
1R01AI105215-01A1
|
|
The role of natural killer T cells in the innate response to lung infection
|
KRONENBERG, MITCHELL
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
CA
|
$442,500
|
Pneumonia
|
2014
|
NIAID
|
5F31AI089015-05
|
|
The role of Pseudomonas aeruginosa ExoS during early pneumonia.
|
RANGEL, STEPHANIE
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$26,676
|
Pneumonia
|
2014
|
NIAID
|
5R01AI099269-03
|
|
Validating targets in p. aeruginosa type III secretion using chemical probes
|
MOIR, DONALD
|
MICROBIOTIX, INC
|
MA
|
$851,764
|
Pneumonia
|
2014
|
NIAID
|
1R21AI105714-01A1
|
|
Probing novel innate immune detection mechanisms using an intracellular bacterial
|
LUO, ZHAO-QING
|
PURDUE UNIVERSITY
|
IN
|
$186,618
|
Pneumonia
|
2014
|
NIAID
|
1R21AI103651-01A1
|
|
Mechanism of Phosphorylcholination of EF-Tu on Pseudomonas aeruginosa
|
GOLDBERG, JOANNA
|
EMORY UNIVERSITY
|
GA
|
$231,900
|
Pneumonia
|
2014
|
NIAID
|
5R01AI093451-04
|
|
Boosting Innate Immunity Through HIF to Treat Antibiotic-Resistant Infections
|
NIZET, VICTOR
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$973,816
|
Pneumonia
|
2014
|
NIAID
|
5R01AI100114-03
|
|
Enhancing neonatal immunity to Streptococcus pneumoniae
|
MALLEY, RICHARD
|
CHILDREN'S HOSPITAL CORPORATION
|
MA
|
$396,500
|
Pneumonia
|
2014
|
OD
|
5R01AI100114-03
|
|
Enhancing neonatal immunity to Streptococcus pneumoniae
|
MALLEY, RICHARD
|
CHILDREN'S HOSPITAL CORPORATION
|
MA
|
$99,942
|
Pneumonia
|
2014
|
NINR
|
5R00NR012016-05
|
|
Exhaled Biomarkers of Pulmonary Infection in the Critically Ill
|
MONTPETIT, ALISON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$243,631
|
Pneumonia
|
2014
|
NHLBI
|
1P01HL114453-01A1
|
7097
|
Intra- and extra-cellular signaling by Cardiolipin in Lung injury
|
KAGAN, VALERIAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$380,259
|
Pneumonia
|
2014
|
NHLBI
|
1P01HL114453-01A1
|
7098
|
Dysregulation of Innate Immune response in Bacterial Pneumonia by Cardiolipin
|
RAY, PRABIR
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$406,160
|
Pneumonia
|
2014
|
NHLBI
|
5R01HL062052-18
|
|
T cells and P carinii Pneumonia
|
KOLLS, JAY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$390,160
|
Pneumonia
|
2014
|
NHLBI
|
5R01HL079392-09
|
|
Cytokine-stimulated systemic defenses during pneumococcal pneumonia
|
MIZGERD, JOSEPH
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$398,027
|
Pneumonia
|
2014
|
NIAID
|
1R41AI109926-01
|
|
Development of VPL Vaccine for RSV
|
BLANCO, JORGE
|
SIGMOVIR BIOSYSTEMS, INC.
|
MD
|
$225,000
|
Pneumonia
|
2014
|
NIAID
|
5R01AI068741-08
|
|
HLA class II transgenic mouse models for S. aureus infections and superantigens
|
DAVID, CHELLA
|
MAYO CLINIC ROCHESTER
|
MN
|
$397,500
|
Pneumonia
|
2014
|
NIAID
|
5R01AI088255-05
|
|
Regulation of the physiologic and pathologic activation of the NLRP3-inflammasome
|
DUNCAN, JOSEPH
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$427,013
|
Pneumonia
|
2014
|
NIAID
|
5R21AI101775-02
|
|
Structural studies of respiratory syncytial virus
|
WRIGHT, ELIZABETH
|
EMORY UNIVERSITY
|
GA
|
$195,000
|
Pneumonia
|
2014
|
NIAID
|
5R01AI097307-03
|
|
Molecular mechanism regulating periplasmic proteolysis in bacterial pathogenesis
|
SONDERMANN, HOLGER
|
CORNELL UNIVERSITY
|
NY
|
$386,719
|
Pneumonia
|
2014
|
NIAID
|
5R21AI099698-02
|
|
Early Events in the Pathogenesis of Pneumonic Plague
|
GOLDMAN, WILLIAM
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$228,000
|
Pneumonia
|
2014
|
NIAID
|
1U19AI109680-01
|
7496
|
Inhibitors of Coronavirus Fidelity and Cap Methylation as Broadly Applicable
|
DENISON, MARK
|
VANDERBILT UNIVERSITY
|
TN
|
$996,397
|
Pneumonia
|
2014
|
NIAID
|
1U19AI109680-01
|
7500
|
Screening Core
|
BOSTWICK, JAMES
|
SOUTHERN RESEARCH INSTITUTE
|
AL
|
$1,194,768
|
Pneumonia
|
2014
|
NIA
|
1R01AG045044-01A1
|
|
Effects of aging and HIV infection on the response to pneumococcal vaccine
|
PIROFSKI, LIISE-ANNE
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
NY
|
$519,532
|
Pneumonia
|
2014
|
NIAID
|
5R01AI089728-05
|
|
Receptor recognition mechanisms of coronaviruses
|
LI, FANG
|
UNIVERSITY OF MINNESOTA
|
MN
|
$373,725
|
Pneumonia
|
2014
|
NIAID
|
5R21AI103407-02
|
|
Regulation of NETosis in antibacterial lung defense
|
REMOLD-O'DONNELL, EILEEN
|
CHILDREN'S HOSPITAL CORPORATION
|
MA
|
$175,500
|
Pneumonia
|
2014
|
NIAID
|
5R21AI103769-02
|
|
Glucose regulation of bacterial virulence in diabetes and hyperglycemia
|
YOTHER, JANET
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$183,750
|
Pneumonia
|
2014
|
NIAID
|
1F31AI104172-01A1
|
|
Hydrogen Peroxide and Capsule Production in Streptococcus pneumoniae
|
HAUSER, JOCELYN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$32,573
|
Pneumonia
|
2014
|
NEI
|
2R01EY014362-10A1
|
|
Toll Like Receptors in Bacterial Keratitis
|
PEARLMAN, ERIC
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$396,250
|
Pneumonia
|
2014
|
NIAID
|
1F31AI104177-01A1
|
|
Pneumococcal Cardiotoxicity During Invasive Pneumococcal Disease
|
BROWN, ARMAND
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
TX
|
$30,209
|
Pneumonia
|
2014
|
NIGMS
|
5R01GM042569-25
|
|
Structure and Mechanism of Metalloregulatory Proteins
|
GIEDROC, DAVID
|
INDIANA UNIVERSITY BLOOMINGTON
|
IN
|
$427,348
|
Pneumonia
|
2014
|
OD
|
5R01AI101898-03
|
|
Innovative Biomarkers to Predict Radiation Lung Injury
|
MEDHORA, MEETHA
|
MEDICAL COLLEGE OF WISCONSIN
|
WI
|
$381,948
|
Pneumonia
|
2014
|
NIMHD
|
5R01MD004011-06
|
|
Impact of PCV on disease and colonization among Native American communities
|
O'BRIEN, KATHERINE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$359,855
|
Pneumonia
|
2014
|
NIAID
|
1U19AI109713-01
|
8682
|
Broad spectrum Tricyclics GyrB, ParE inhibitors for antibacterial applications
|
BARTIZAL, KENNETH
|
TRIUS THERAPEUTICS, INC.
|
CA
|
$731,729
|
Pneumonia
|
2014
|
NIAID
|
1U19AI109713-01
|
8688
|
Animal Model Core
|
PERLIN, DAVID
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
NJ
|
$698,474
|
Pneumonia
|
2014
|
NIDCD
|
5R01DC006917-10
|
|
Otitis Media-associated pneumococcal genes
|
METZGER, DENNIS
|
ALBANY MEDICAL COLLEGE
|
NY
|
$485,859
|
Pneumonia
|
2014
|
NIGMS
|
5R01GM100192-03
|
|
Hepatic Lectin Receptors in Glycoprotein Homeostasis
|
MARTH, JAMEY
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
CA
|
$370,500
|
Pneumonia
|
2014
|
NHLBI
|
5K24HL111316-03
|
|
Forging a road to personalized medicine in interstitial lung diseases
|
FLAHERTY, KEVIN
|
UNIVERSITY OF MICHIGAN
|
MI
|
$181,756
|
Pneumonia
|
2014
|
NHLBI
|
5R01HL113495-03
|
|
Macrophage effector functions during respiratory fungal infection
|
WRIGHT, TERRY
|
UNIVERSITY OF ROCHESTER
|
NY
|
$378,525
|
Pneumonia
|
2014
|
NIDA
|
1R01DA037102-01
|
|
Marijuana smoke promotes dysfunctional macrophage responses to HIV and pneumonia
|
ROTH, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$454,643
|
Pneumonia
|
2014
|
NIAID
|
1R01AI108479-01A1
|
|
Mechanisms of Impaired HIV-associated B cell and Pneumococcal Vaccine responses
|
JANOFF, EDWARD
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$543,677
|
Pneumonia
|
2014
|
NIAID
|
5R01AI063517-10
|
|
Challenges in beta-Lactamase Mediated Resistance
|
BONOMO, ROBERT
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$311,850
|
Pneumonia
|
2014
|
NHLBI
|
2K24HL087713-06A1
|
|
Patient-Oriented Research and Mentoring in HIV-associated Pulmonary Diseases
|
HUANG, LAURENCE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$181,443
|
Pneumonia
|
2014
|
NIAID
|
5R01AI034937-19
|
|
Genetics of Iron Acquisition by Legionella pneumophila
|
CIANCIOTTO, NICHOLAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$377,438
|
Pneumonia
|
2014
|
NIAID
|
5R01AI090782-05
|
|
Molecular Antibiotic Resistance Arrays for clinical microbiology laboratories
|
KEIM, PAUL
|
TRANSLATIONAL GENOMICS RESEARCH INST
|
AZ
|
$868,077
|
Pneumonia
|
2014
|
NIAID
|
5R01AI098843-03
|
|
Multiplex diagnostic for biothreat C. psittaci & non-threat respiratory pathogens
|
DEAN, DEBORAH
|
CHILDREN'S HOSPITAL & RES CTR AT OAKLAND
|
CA
|
$1,071,188
|
Pneumonia
|
2014
|
NHLBI
|
5R01HL105903-04
|
|
A Multifaceted Intervention to Reduce Ventilator-Associated Pneumonia in the ICU
|
BERENHOLTZ, SEAN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$446,370
|
Pneumonia
|
2014
|
NHLBI
|
5R01HL113382-03
|
|
Regulation of host inflammatory responses and outcome in melioidosis by TLR5
|
WEST, TIMOTHY
|
UNIVERSITY OF WASHINGTON
|
WA
|
$635,696
|
Pneumonia
|
2014
|
NIAID
|
5R01AI093646-03
|
|
Pulmonary Defenses Against Intracellular Infection
|
SKERRETT, SHAWN
|
UNIVERSITY OF WASHINGTON
|
WA
|
$386,250
|
Pneumonia
|
2014
|
NIAID
|
5R01AI098775-03
|
|
RBD recombinant protein-based SARS vaccine for biodefense
|
HOTEZ, PETER
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$1,134,359
|
Pneumonia
|
2014
|
NIAID
|
5R21AI107165-02
|
|
Broad spectrum antivirals targeting envelope proteolysis and viral uncoating
|
SIMMONS, GRAHAM
|
BLOOD SYSTEMS RESEARCH INSTITUTE
|
CA
|
$221,500
|
Pneumonia
|
2014
|
NIAID
|
5R01AI098771-03
|
|
Targeting superbugs: discovery and development of new broad-spectrum lipopeptides
|
LI, JIAN
|
MONASH UNIVERSITY
|
AUSTRA
|
$829,212
|
Pneumonia
|
2014
|
NIAID
|
5R01AI091322-04
|
|
Role of anti-SARS-CoV T cell response in pathogenesis
|
PERLMAN, STANLEY
|
UNIVERSITY OF IOWA
|
IA
|
$377,500
|
Pneumonia
|
2014
|
NIDCD
|
5R01DC006452-08
|
|
Effect of the Middle Ear Inflammation on the Inner Ear
|
JUHN, STEVEN
|
UNIVERSITY OF MINNESOTA
|
MN
|
$295,838
|
Pneumonia
|
2014
|
NHLBI
|
5R01HL118408-03
|
|
Oxidative Burst in Influenza and MRSA Co-infection
|
SUN, KEER
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
NE
|
$368,725
|
Pneumonia
|
2014
|
NHLBI
|
5R01HL119190-02
|
|
Directed Culturing of Pneumocystis Using Metatranscriptomics
|
CUSHION, MELANIE
|
UNIVERSITY OF CINCINNATI
|
OH
|
$410,954
|
Pneumonia
|
2014
|
NIAID
|
5R01AI085524-05
|
|
Broad Spectrum Neutralizing Human Abs to SARS and Related Coronaviruses
|
MARASCO, WAYNE
|
DANA-FARBER CANCER INST
|
MA
|
$1,078,057
|
Pneumonia
|
2014
|
NIAID
|
5R01AI087674-05
|
|
Mechanisms of PVL-induced Acute Lung Injury
|
DIEP, BINH
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$407,929
|
Pneumonia
|
2014
|
NIAID
|
5R21AI107978-02
|
|
Farnesylated effectors of Legionella
|
ABU KWAIK, YOUSEF
|
UNIVERSITY OF LOUISVILLE
|
KY
|
$187,500
|
Pneumonia
|
2014
|
NIAID
|
5R21AI100631-02
|
|
Identification of new compounds against fungal microbes
|
DEL POETA, MAURIZIO
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$197,448
|
Pneumonia
|
2014
|
NIAID
|
5R01AI106786-02
|
|
Ecological and genetic contributions to the spread of resistance in pneumococcus
|
HANAGE, WILLIAM
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
MA
|
$507,713
|
Pneumonia
|
2014
|
NIAID
|
5R21AI107302-02
|
|
Markers predicting response to therapy for KPC-producing Klebsiella pneumoniae
|
DOI, YOHEI
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$189,650
|
Pneumonia
|
2014
|
NHLBI
|
5K23HL096054-05
|
|
Effect of macrolides as immunomodulators in patients with sepsis and pneumonia
|
RESTREPO, MARCOS
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
TX
|
$137,700
|
Pneumonia
|
2014
|
NHLBI
|
5R01HL104053-05
|
|
MicroRNA uridylation by Zcchc11 regulates pulmonary inflammation
|
JONES, MATTHEW
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$397,054
|
Pneumonia
|
2014
|
NHLBI
|
5R01HL102371-05
|
|
A novel proteolytic system of pulmonary inflammation
|
GAGGAR, AMIT
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$357,786
|
Pneumonia
|
2014
|
NIAID
|
5R01AI090802-05
|
|
Optimization of Neoglycoside Antibiotics for Nosocomial Pathogens and Select Agen
|
DRUSANO, GEORGE
|
UNIVERSITY OF FLORIDA
|
FL
|
$724,489
|
Pneumonia
|
2014
|
NIAID
|
5R01AI095424-03
|
|
Redox Regulation of Lung Mitochondrial Biogenesis in Sepsis/Pneumonia
|
PIANTADOSI, CLAUDE
|
DUKE UNIVERSITY
|
NC
|
$392,500
|
Pneumonia
|
2014
|
NIEHS
|
5U19ES019544-05
|
5631
|
Project 2: Role of ENP Physicochemical Properties on Biokinetics and Response in
|
POUNDS, JOEL
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
WA
|
$317,307
|
Pneumonia
|
2014
|
NHLBI
|
5R01HL108949-03
|
|
Mechanisms of impaired neutrophil responses in postinfluenza bacterial pneumonia
|
DENG, JANE
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$377,300
|
Pneumonia
|
2014
|
NIAID
|
5K08AI095352-04
|
|
Innate and acquired immune responses to novel pneumococcal T cell antigens
|
MOFFITT, KRISTIN
|
CHILDREN'S HOSPITAL CORPORATION
|
MA
|
$133,515
|
Pneumonia
|
2014
|
NIAID
|
5K25AI100946-03
|
|
Bacterial virulence factors contributing to virus-associated pneumonias
|
SMITH, AMBER
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$85,014
|
Pneumonia
|
2014
|
NIAID
|
5K01AI103028-02
|
|
Carbapenem-Resistant Klebsiella Pneumoniae in Long-Term Acute Care Hospitals
|
HAN, JENNIFER
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$133,758
|
Pneumonia
|
2014
|
NIAID
|
5F32AI098358-03
|
|
Type VI Protein Secretion in an Emerging Multidrug-Resistant Pathogen
|
GEISINGER, EDWARD
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$58,946
|
Pneumonia
|
2014
|
NIDCD
|
5R01DC004562-17
|
|
Up-regulation of Mucin Gene Transcription-Otitis Media
|
LI, JIAN-DONG
|
GEORGIA STATE UNIVERSITY
|
GA
|
$297,237
|
Pneumonia
|
2014
|
NHLBI
|
5R01HL111449-03
|
|
The Biology of LIF During Pneumonia
|
QUINTON, LEE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$401,065
|
Pneumonia
|
2014
|
NIAID
|
5R01AI095569-04
|
|
Role of the Epithelial Growth Factor Receptor in SARS Coronavirus Pathogenesis
|
FRIEMAN, MATTHEW
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$528,500
|
Pneumonia
|
2014
|
NHLBI
|
5K08HL114641-03
|
|
IQGAP1 In Vascular Barrier Regulation During Acute Lung Injury
|
BHATTACHARYA, MALLAR
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$131,490
|
Pneumonia
|
2014
|
NIAID
|
5R01AI038446-20
|
|
Mechanisms of pneumococcal persistence during carriage.
|
WEISER, JEFFREY
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$364,992
|
Pneumonia
|
2014
|
NIAID
|
5R01AI091702-04
|
|
Host-associated regulation of P. aeruginosa colonization and virulence
|
HOGAN, DEBORAH
|
DARTMOUTH COLLEGE
|
NH
|
$395,000
|
Pneumonia
|
2014
|
NHLBI
|
2R01HL092020-05A1
|
|
Enhancing neutrophil function in neutropenia-related pneumonia
|
LUO, HONGBO
|
CHILDREN'S HOSPITAL CORPORATION
|
MA
|
$438,750
|
Pneumonia
|
2014
|
NIAID
|
5F31AI108086-02
|
|
Host protein prenyl transferases as modifiers of effectors of pathogenic bacteria
|
WRIGHT, ELIA
|
UNIVERSITY OF MICHIGAN
|
MI
|
$32,580
|
Pneumonia
|
2014
|
NIAID
|
5P01AI060699-09
|
5176
|
Role of anti-SARS-CoV T cell response in pathogenesis
|
PERLMAN, STANLEY
|
UNIVERSITY OF IOWA
|
IA
|
$324,460
|
Pneumonia
|
2014
|
NIAID
|
5P01AI060699-09
|
5177
|
Entry and pathogenesis of two human coronaviruses
|
GALLAGHER, THOMAS
|
LOYOLA UNIVERSITY CHICAGO
|
IL
|
$335,229
|
Pneumonia
|
2014
|
NIAID
|
5P01AI060699-09
|
5178
|
Biology of ACE2 activity in the airway epithelium
|
MCCRAY, PAUL
|
UNIVERSITY OF IOWA
|
IA
|
$304,341
|
Pneumonia
|
2014
|
NIAID
|
5P01AI060699-09
|
5179
|
A novel strategy for developing a SARS-CoV vaccine
|
ENJUANES, LUIS
|
CONSEJO SUPERIOR DE INVESTIGACIONES CIEN
|
SPAIN
|
$307,973
|
Pneumonia
|
2014
|
NIAID
|
5P01AI060699-09
|
5180
|
Animal Core
|
PERLMAN, STANLEY
|
UNIVERSITY OF IOWA
|
IA
|
$226,803
|
Pneumonia
|
2014
|
NIAID
|
5P01AI060699-09
|
5181
|
Administrative Core
|
PERLMAN, STANLEY
|
UNIVERSITY OF IOWA
|
IA
|
$96,990
|
Pneumonia
|
2014
|
NIAID
|
5R01AI095307-03
|
|
Alternative macrophage activation in acute Pseudomonas pneumonia
|
FEOLA, DAVID
|
UNIVERSITY OF KENTUCKY
|
KY
|
$362,213
|
Pneumonia
|
2014
|
NIGMS
|
5P20GM103648-02
|
8210
|
Development of an RSV Vaccine by Molecular Manipulation of the Viral Matrix Prot
|
OOMENS, TOM
|
OKLAHOMA STATE UNIVERSITY STILLWATER
|
OK
|
$246,942
|
Pneumonia
|
2014
|
NIGMS
|
5P20GM103648-02
|
8213
|
Neutrophil-Mediated Acute Lung Injury in Influenza Virus Pneumonia
|
NARASARAJU, TELUGU
|
OKLAHOMA STATE UNIVERSITY STILLWATER
|
OK
|
$247,447
|
Pneumonia
|
2014
|
NIAID
|
5U19AI090023-05
|
7812
|
Systems biological analyses of adaptive responses to vaccination
|
AHMED, RAFI
|
EMORY UNIVERSITY
|
GA
|
$574,495
|
Pneumonia
|
2014
|
NIAID
|
5U19AI090023-05
|
7814
|
Clinical and Statistical
|
MULLIGAN, MARK
|
EMORY UNIVERSITY
|
GA
|
$662,585
|
Pneumonia
|
2014
|
NHLBI
|
5R01HL116316-03
|
|
Molecular Imaging for Macrophage-Associated Pulmonary Inflammation
|
JAIN, SANJAY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$396,900
|
Pneumonia
|
2014
|
NIAAA
|
5R01AA017627-05
|
|
Zinc deficiency in the alcoholic lung
|
GUIDOT, DAVID
|
EMORY UNIVERSITY
|
GA
|
$257,287
|
Pneumonia
|
2014
|
NIDCD
|
5R00DC011322-05
|
|
Insights from Comparative Genomics for the Treatment of Pneumococcal Infections
|
HILLER, NATALIA
|
CARNEGIE-MELLON UNIVERSITY
|
PA
|
$238,055
|
Pneumonia
|
2014
|
NINDS
|
5R01NS056457-09
|
|
Sensitization to Brain Antigens Following Stroke
|
BECKER, KYRA
|
UNIVERSITY OF WASHINGTON
|
WA
|
$334,588
|
Pneumonia
|
2014
|
NHLBI
|
1R01HL119682-01A1
|
|
Post Viral Bacterial Pneumonia: Role of MicroRNA and Autophagy
|
BHAN, URVASHI
|
UNIVERSITY OF MICHIGAN
|
MI
|
$388,750
|
Pneumonia
|
2014
|
NIAID
|
5K24AI104831-02
|
|
Patient-Oriented Research on Hospital-Acquired Pathogens
|
HAUSER, ALAN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$100,048
|
Pneumonia
|
2014
|
NIDDK
|
5R01DK041479-24
|
|
Retinoid Nutritional Status and Immune Function
|
ROSS, A
|
PENNSYLVANIA STATE UNIVERSITY-UNIV PARK
|
PA
|
$275,163
|
Pneumonia
|
2014
|
OD
|
5R01DK041479-24
|
|
Retinoid Nutritional Status and Immune Function
|
ROSS, A
|
PENNSYLVANIA STATE UNIVERSITY-UNIV PARK
|
PA
|
$50,000
|
Pneumonia
|
2014
|
NHLBI
|
1K08HL119359-01A1
|
|
Matrix Metalloproteinase Driven Lung Inflammation in RSV disease
|
KONG, MICHELE
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$118,344
|
Pneumonia
|
2014
|
NHLBI
|
5K01HL108860-04
|
|
Hypercapnia and neutrophil function in pulmonary host defense
|
GATES, KHALILAH
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$134,217
|
Pneumonia
|
2014
|
NHLBI
|
5F31HL114360-03
|
|
Influence of Macrophage NF-kB Activation on the Outcome of Pneumococcal Pneumonia
|
COLEMAN, FADIE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$30,012
|
Pneumonia
|
2014
|
NIAID
|
5R01AI101018-03
|
|
Antibiotics from nose and throat commensals that impact pathogen colonization
|
LEMON, KATHERINE
|
FORSYTH INSTITUTE
|
MA
|
$442,247
|
Pneumonia
|
2014
|
NHLBI
|
5P01HL098067-05
|
6073
|
Extracellular Matrix in the Innate Immune Response in Lung Inflammation
|
WIGHT, THOMAS
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
WA
|
$411,439
|
Pneumonia
|
2014
|
NHLBI
|
5P01HL098067-05
|
6074
|
Thymic Stromal Lymphopoietin (TSLP) and Lung Inflammation and Imm
|
ZIEGLER, STEVEN
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
WA
|
$348,056
|
Pneumonia
|
2014
|
NHLBI
|
5P01HL098067-05
|
6076
|
Role of Stromelysin 2 (MMP-10) in Lung Immunity
|
PARKS, WILLIAM
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
WA
|
$536,930
|
Pneumonia
|
2014
|
NHLBI
|
5P01HL098067-05
|
6080
|
Control of regulatory T cell homeostasis and function by the TH1
|
CAMPBELL, DANIEL
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
WA
|
$276,686
|
Pneumonia
|
2014
|
NHLBI
|
5P01HL098067-05
|
6081
|
Administrative Core
|
ZIEGLER, STEVEN
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
WA
|
$150,967
|
Pneumonia
|
2014
|
NHLBI
|
5P01HL098067-05
|
6082
|
Mouse Models of Pulmonary Inflammation Core
|
FREVERT, CHARLES
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
WA
|
$278,614
|
Pneumonia
|
2014
|
NHLBI
|
5P01HL098067-05
|
6083
|
Cell Imaging Core
|
VERNON, ROBERT
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
WA
|
$233,590
|
Pneumonia
|
2014
|
NHLBI
|
5K08HL112849-02
|
|
Modulation of host immune defense by Pneumocystis beta-glucans
|
CARMONA PORQUERA, EVA
|
MAYO CLINIC ROCHESTER
|
MN
|
$127,035
|
Pneumonia
|
2014
|
NIAID
|
1R21AI107131-01A1
|
|
Type III Secretion Translocon Structure and Function
|
RIETSCH, ARNE
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$237,750
|
Pneumonia
|
2014
|
NIAID
|
1R21AI111753-01
|
|
Circumventing Antibiotic Resistance with Novel Gene-Silencing Therapeutics
|
GREENBERG, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
TX
|
$215,059
|
Pneumonia
|
2014
|
FIC
|
5D43TW007585-07
|
|
Infectious Diseases and Child Health in Pakistan Research Training Program.
|
ZAIDI, ANITA
|
AGA KHAN UNIVERSITY
|
PAKIST
|
$243,000
|
Pneumonia
|
2014
|
OD
|
5U19AI067798-10
|
6749
|
Inflammation and Radiation-induced Lung Injury
|
TING, JENNY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$267,301
|
Pneumonia
|
2014
|
NIDA
|
5K05DA033881-03
|
|
Opioid Drug abuse in the context of opportunistic infection increases susceptibil
|
ROY, SABITA
|
UNIVERSITY OF MINNESOTA
|
MN
|
$132,192
|
Pneumonia
|
2014
|
NIAID
|
5R01AI066304-09
|
|
Conjugate vaccine impact on pneumococcal carriage, disease, and population geneti
|
FINKELSTEIN, JONATHAN
|
HARVARD PILGRIM HEALTH CARE, INC.
|
MA
|
$763,538
|
Pneumonia
|
2014
|
NIAID
|
5U19AI070412-09
|
6713
|
Structure and action of CARDS toxin
|
HART, PETER
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
TX
|
$149,426
|
Pneumonia
|
2014
|
OD
|
5U19AI070412-09
|
6713
|
Structure and action of CARDS toxin
|
HART, PETER
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
TX
|
$735
|
Pneumonia
|
2014
|
NIAID
|
5R01AI096735-04
|
|
An evidence based algorithm for diagnosis of tuberculosis in HIV patients
|
MENDELSON, MARC
|
UNIVERSITY OF CAPE TOWN
|
SO AFR
|
$23,635
|
Pneumonia
|
2014
|
NIAID
|
5U19AI100625-03
|
6155
|
System Immunogenetics of SARS-CoV Infection
|
BARIC, RALPH
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$334,030
|
Pneumonia
|
2014
|
NIAID
|
5U19AI100625-03
|
6156
|
System Immunogenetics of Influenza-Induced Innate and Adaptive Immunity in the L
|
HEISE, MARK
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$334,030
|
Pneumonia
|
2014
|
NIAID
|
5U19AI100625-03
|
6157
|
System Immunogenetics of Innate Immune and Inflammatory Responses to West Nile V
|
GALE, MICHAEL
|
UNIVERSITY OF WASHINGTON
|
WA
|
$377,554
|
Pneumonia
|
2014
|
NIAID
|
5U19AI100625-03
|
6161
|
High-Throughput Molecular Profiling Core
|
KATZE, MICHAEL
|
UNIVERSITY OF WASHINGTON
|
WA
|
$845,786
|
Pneumonia
|
2014
|
NHLBI
|
5R01HL091958-07
|
|
Neutrophil Accumulation in Bacterial Pneumonia
|
JEYASEELAN, SAMITHAMBY
|
LOUISIANA STATE UNIV A&M COL BATON ROUGE
|
LA
|
$365,693
|
Pneumonia
|
2014
|
NIAID
|
5K22AI104799-02
|
|
Multiscale Modeling of Pilin Subunit Recognition by Pneumoccus Sortase C enzymes
|
WERESZCZYNSKI, JEFFERY
|
ILLINOIS INSTITUTE OF TECHNOLOGY
|
IL
|
$103,464
|
Pneumonia
|
2014
|
NIAID
|
1R01AI111965-01
|
|
New Tricks for 'Old' Drugs: PK/PD of Polymyxin Nonantibiotic Combinations
|
LI, JIAN
|
MONASH UNIVERSITY
|
AUSTRA
|
$905,775
|
Pneumonia
|
2014
|
NHLBI
|
5P01HL076100-10
|
5035
|
CD4-Dependent help for mucosal vaccine responses
|
SHELLITO, JUDD
|
LSU HEALTH SCIENCES CENTER
|
LA
|
$337,127
|
Pneumonia
|
2014
|
NHLBI
|
5P01HL076100-10
|
5036
|
CD4-Dependent vaccination against pneumocystis
|
KOLLS, JAY
|
LSU HEALTH SCIENCES CENTER
|
LA
|
$368,852
|
Pneumonia
|
2014
|
NHLBI
|
5P01HL076100-10
|
5037
|
Vaccine strategies against pneumocystis in non-human primates
|
NORRIS, KAREN
|
LSU HEALTH SCIENCES CENTER
|
LA
|
$167,834
|
Pneumonia
|
2014
|
NHLBI
|
5P01HL076100-10
|
5039
|
Non-human primate core
|
NORRIS, KAREN
|
LSU HEALTH SCIENCES CENTER
|
LA
|
$667,280
|
Pneumonia
|
2014
|
NHLBI
|
5P01HL076100-10
|
5040
|
Antigen Discovery Core
|
ZHENG, MINGQUAN
|
LSU HEALTH SCIENCES CENTER
|
LA
|
$109,182
|
Pneumonia
|
2014
|
NIAID
|
5P01AI078894-05
|
7795
|
Defenses against Acute Chronic Infection with C pneumoniae
|
INGALLS, ROBIN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$188,630
|
Pneumonia
|
2014
|
NIAID
|
5P01AI078894-05
|
7798
|
In Vitro Core
|
MADICO, GUILLERMO
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$167,159
|
Pneumonia
|
2014
|
NIAID
|
5P01AI078894-05
|
7799
|
Animal Core
|
WETZLER, LEE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$287,137
|
Pneumonia
|
2014
|
NIAID
|
5R01AI108197-02
|
|
Determinants of Coronavirus Fidelity in Replication and Pathogenesis
|
DENISON, MARK
|
VANDERBILT UNIVERSITY
|
TN
|
$547,101
|
Pneumonia
|
2014
|
NHLBI
|
5R01HL062150-22
|
|
Pneumocystis carinii: Macrophage & Epithelial Activation
|
LIMPER, ANDREW
|
MAYO CLINIC ROCHESTER
|
MN
|
$389,550
|
Pneumonia
|
2014
|
NHLBI
|
5R01HL119770-02
|
|
Adaptive immunity against Pneumocystis
|
STEELE, CHAD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$360,150
|
Pneumonia
|
2014
|
NIAID
|
1U19AI110819-01
|
6908
|
Genomics of Antibiotic Resistance in Bacterial Pathogens
|
ADAMS, MARK
|
J. CRAIG VENTER INSTITUTE, INC.
|
MD
|
$352,105
|
Pneumonia
|
2014
|
NIAID
|
5R37AI041699-19
|
|
Genetic Analysis of Legionella Phagosome Trafficking
|
ROY, CRAIG
|
YALE UNIVERSITY
|
CT
|
$585,318
|
Pneumonia
|
2014
|
NIAID
|
5K08AI097223-04
|
|
Role of Macrophage Migration Inhibitory Factor (MIF) in Pneumococcal Pathogenesis
|
DAS, RITUPARNA
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$133,758
|
Pneumonia
|
2014
|
NHLBI
|
5R01HL068153-11
|
|
NF-kB and Innate Immunity in the Lungs
|
MIZGERD, JOSEPH
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$401,065
|
Pneumonia
|
2014
|
NIAAA
|
5R24AA019661-04
|
|
Clinical Resource for Lung and Alcohol Investigations
|
BURNHAM, ELLEN
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$494,286
|
Pneumonia
|
2014
|
NIA
|
5R01AG045973-02
|
|
Immune response to pneumococcal vaccination in aging HIV positive adults.
|
WESTERINK, M.A.
|
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS
|
OH
|
$314,825
|
Pneumonia
|
2014
|
NIAID
|
5U01AI110466-02
|
|
The nasopharyngeal microbiome and respiratory disease in African children
|
NICOL, MARK
|
UNIVERSITY OF CAPE TOWN
|
SO AFR
|
$339,401
|
Pneumonia
|
2014
|
NHLBI
|
1F32HL120551-01A1
|
|
Distinct roles of LIF and OSM during pneumonia
|
TRABER, KATRINA
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$63,122
|
Pneumonia
|
2014
|
NIDCD
|
1R01DC013554-01A1
|
|
Pneumococcal transition from nasopharyngeal biofilm carriage to otitis media
|
CAMPAGNARI, ANTHONY
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$343,941
|
Pneumonia
|
2014
|
NIAID
|
5R01AI048935-13
|
|
Mechanisms and Population Genomics of Pneumococcal Antigenic Diversity
|
LIPSITCH, MARC
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
MA
|
$713,860
|
Pneumonia
|
2014
|
NIAID
|
5P01AI061093-11
|
6105
|
Genetic dissection of inborn errors of antibody response to pneumococcal glycans
|
CASANOVA, JEAN-LAURENT
|
ROCKEFELLER UNIVERSITY
|
NY
|
$540,840
|
Pneumonia
|
2014
|
NIAID
|
5R21AI103480-02
|
|
Identification of protective pneumococcal antigens from a surface protein library
|
LU, YINGJIE
|
CHILDREN'S HOSPITAL CORPORATION
|
MA
|
$194,354
|
Pneumonia
|
2014
|
NIAAA
|
5R21AA021205-02
|
|
Chronic Ethanol Consumption and Pulmonary Immune Suppression
|
LEGGE, KEVIN
|
UNIVERSITY OF IOWA
|
IA
|
$173,933
|
Pneumonia
|
2014
|
NIGMS
|
5R01GM104306-02
|
|
Augmentation of Innate Anti-Microbial Immunity by TLR4 Agonists
|
SHERWOOD, EDWARD
|
VANDERBILT UNIVERSITY
|
TN
|
$295,271
|
Pneumonia
|
2014
|
NHLBI
|
1K24HL123342-01
|
|
Mentoring and Patient-Oriented Research in HIV Obstructive Lung Disease
|
MORRIS, ALISON
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$114,212
|
Pneumonia
|
2014
|
NIAID
|
1U01AI112406-01
|
|
Nikkomycin Z treatment of primary pneumonia due to Coccidioides
|
LARWOOD, DAVID
|
VALLEY FEVER SOLUTIONS, INC.
|
AZ
|
$211,459
|
Pneumonia
|
2014
|
NIAID
|
5R21AI103451-02
|
|
CRISPR Cas genes and Legionella pneumophila infection
|
CIANCIOTTO, NICHOLAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$193,125
|
Pneumonia
|
2014
|
NIAID
|
1K08AI112506-01
|
|
The Epidemiology of Multi-Drug Resistant Enterobacteriaceae Infections in Childre
|
LOGAN, LATANIA
|
RUSH UNIVERSITY MEDICAL CENTER
|
IL
|
$178,805
|
Pneumonia
|
2014
|
NHLBI
|
5R44HL110444-03
|
|
Micro_patterned Surfaces for Reducing the Risk of Ventilator_Associated Pneumonia
|
REDDY, SHRAVANTHI
|
SHARKLET TECHNOLOGIES, INC.
|
CO
|
$678,767
|
Pneumonia
|
2014
|
NIAAA
|
5F31AA022566-02
|
|
Ethanol, Lung Mesenchymal Stem Cells and Pulmonary Inflammation After Burn Injury
|
IPPOLITO, JILL
|
LOYOLA UNIVERSITY CHICAGO
|
IL
|
$32,719
|
Pneumonia
|
2014
|
NIA
|
7R21AG044755-02
|
|
Detection & Use of Novel Therapeutics to Stimulate NLRP3 Activity in the Elderly
|
STOUT-DELGADO, HEATHER
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$211,875
|
Pneumonia
|
2014
|
NIGMS
|
1SC2GM111170-01
|
|
Characterization of Accessory Factors in Bacterial Transition Metal Import
|
YUKL, ERIK
|
NEW MEXICO STATE UNIVERSITY LAS CRUCES
|
NM
|
$122,080
|
Pneumonia
|
2014
|
NIGMS
|
5P20GM103646-02
|
8320
|
Identifying polyamine dependent mechanisms in pneumococcal pneumonia
|
NANDURI, BINDU
|
MISSISSIPPI STATE UNIVERSITY
|
|
$238,007
|
Pneumonia
|
2014
|
NIAID
|
2R01AI043987-16A1
|
|
Type II Secretion and Legionella pneumophila Infection
|
CIANCIOTTO, NICHOLAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$314,998
|
Pneumonia
|
2014
|
NIAID
|
1R01AI106721-01A1
|
|
Gold Nanocrystal Antibiotics for the Treatment of Multidrug-resistant Gram Negati
|
FELDHEIM, DAN
|
UNIVERSITY OF COLORADO
|
CO
|
$425,001
|
Pneumonia
|
2014
|
NIAID
|
2R01AI056289-12A1
|
|
Recombinant Attenuated Salmonella Vaccines for Humans
|
CURTISS, ROY
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
AZ
|
$454,156
|
Pneumonia
|
2014
|
NIGMS
|
2R01GM091875-14
|
|
POPULATION DYNAMICS AND EVOLUTION OF ANTIBIOTIC TREATMENT AND RESISTANCE
|
LEVIN, BRUCE
|
EMORY UNIVERSITY
|
GA
|
$309,852
|
Pneumonia
|
2014
|
NEI
|
2R01EY016144-10
|
|
Pathogenesis of microbial anterior eye diseases
|
PIER, GERALD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$431,747
|
Pneumonia
|
2014
|
NHLBI
|
1R01HL124103-01
|
|
The Microbiome, Virome and Host Responses Preceding Ventilator-Associated Pneumon
|
MOURANI, PETER
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$768,905
|
Pneumonia
|
2014
|
NIAID
|
1R01AI113211-01
|
|
Control of Endoplasmic Reticulum Tubule Formation by Legionella pneumophila
|
ISBERG, RALPH
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$495,564
|
Pneumonia
|
2014
|
NHLBI
|
2R01HL079395-09A1
|
|
Staphylococcus Aureus Activation of TNF Signaling Pathways
|
PRINCE, ALICE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$396,162
|
Pneumonia
|
2014
|
NHLBI
|
1K08HL121089-01A1
|
|
Contribution of IL36 Family Members to Lung Immunity
|
KOVACH, MELISSA
|
UNIVERSITY OF MICHIGAN
|
MI
|
$132,053
|
Pneumonia
|
2014
|
NHLBI
|
2R01HL081784-07
|
|
Regulation of F box Proteins in Acute Lung Injury
|
MALLAMPALLI, RAMA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$385,000
|
Pneumonia
|
2014
|
NIAID
|
1R21AI113572-01
|
|
Structure and property driven optimization of fatty acid synthesis inhibitors for
|
COHEN, FREDERICK
|
ACHAOGEN, INC.
|
CA
|
$407,104
|
Pneumonia
|
2014
|
NIAID
|
1R21AI109385-01A1
|
|
Targeting P. aeruginosa penicillin-binding proteins for drug discovery
|
DAVIES, CHRISTOPHER
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$224,250
|
Pneumonia
|
2014
|
NINR
|
1R43NR015193-01
|
|
Development of novel, biophysically designed fluids for swallowing disorders
|
CARLSON, ROBERT
|
SWALLOW SOLUTIONS, LLC
|
WI
|
$225,000
|
Pneumonia
|
2014
|
NIAID
|
1F32AI113973-01
|
|
Deciphering the Role of the Coronavirus Macro Domain in SARS-CoV Infection
|
FEHR, ANTHONY
|
UNIVERSITY OF IOWA
|
IA
|
$53,282
|
Pneumonia
|
2014
|
NIAID
|
1R43AI114069-01
|
|
A human monoclonal for RSV prophylaxis
|
ZEITLIN, LARRY
|
MAPP BIOPHARMACEUTICAL, INC.
|
CA
|
$300,000
|
Pneumonia
|
2014
|
NIAID
|
1F30AI114146-01
|
|
Antigen discovery and validation in Pneumocystis pneumonia
|
EDDENS, TAYLOR
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$47,676
|
Pneumonia
|
2014
|
NIAID
|
1F30AI114262-01
|
|
The Role of Group 2 Innate Lymphoid Cells in RSV-Induced Airway Dysfunction
|
STIER, MATTHEW
|
VANDERBILT UNIVERSITY
|
TN
|
$28,989
|
Pneumonia
|
2014
|
NIAID
|
1F32AI114130-01
|
|
Mechanism of Action of Stenotrophomonas maltophilia proteases
|
DUMONT, ASHLEY
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$56,030
|
Pneumonia
|
2014
|
NIGMS
|
3R01GM042569-24S1
|
|
Structure and Mechanism of Metalloregulatory Proteins
|
GIEDROC, DAVID
|
INDIANA UNIVERSITY BLOOMINGTON
|
IN
|
$31,294
|
Pneumonia
|
2014
|
NHLBI
|
1F32HL124951-01
|
|
The Role and Consequences of Anemia in Children with Pneumonia
|
MOSCHOVIS, PETER
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$67,622
|
Pneumonia
|
2014
|
NIAID
|
1R01AI110098-01A1
|
|
Human Airway Colonization by Mycoplasma pneumoniae
|
KRAUSE, DUNCAN
|
UNIVERSITY OF GEORGIA
|
GA
|
$389,125
|
Pneumonia
|
2014
|
NIAID
|
2R01AI053674-10A1
|
|
Mechanistic Studies of Patatin-like Toxins
|
HAUSER, ALAN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$379,206
|
Pneumonia
|
2014
|
NIGMS
|
2U54GM088558-06
|
5072
|
Understanding and controlling antibiotic resistance
|
COHEN, THEODORE
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
MA
|
$42,050
|
Pneumonia
|
2014
|
NHLBI
|
268201100022C-8-0-1
|
|
TAS::75 0872:: LUNG TISSUE RESEARCH CONSORTIUM: RADIOLOGY CENTER
|
BARTHOLMAI, BRIAN
|
MAYO CLINIC ROCHESTER
|
|
$530,809
|
Pneumonia
|
2014
|
NHLBI
|
268201100021C-5-0-1
|
|
TAS:: 75 0872:: TAS LUNG TISSUE RESEACH CONSORTIUM CLINICAL CENTER
|
CRINER, GERARD
|
TEMPLE UNIV OF THE COMMONWEALTH
|
|
$542,181
|
Pneumonia
|
2014
|
NIAID
|
1R56AI107033-01A1
|
|
Characterization of tRNA-derived RNA Fragments (tRFs) in Respiratory Syncytial Vi
|
BAO, XIAOYONG
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$386,979
|
Pneumonia
|
2014
|
FIC
|
1K01TW009988-01
|
|
Pulse oximetry for childhood pneumonia in rural Bangladesh
|
MCCOLLUM, ERIC
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$153,738
|
Pneumonia
|
2014
|
NIAID
|
1R56AI108654-01
|
|
REGULATION OF MEMORY B CELL RESPONSES TO POLYSACCHARIDE ANTIGENS
|
HAAS, KAREN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$259,000
|
Pneumonia
|
2014
|
NIAID
|
1R56AI104788-01A1
|
|
iNKT and B Cell Cooperation in Immunity and Host Defense
|
LEADBETTER, ELIZABETH
|
TRUDEAU INSTITUTE, INC.
|
NY
|
$243,750
|
Pneumonia
|
2014
|
NIAID
|
4R33AI098705-03
|
|
Multiplexed targeting of Pseudomonas aeruginosa essential outer membrane proteins
|
HUNG, DEBORAH
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$427,455
|
Pneumonia
|
2014
|
NIAID
|
4R33AI098731-03
|
|
Discovery of Polymyxin-based Antibacterial Agents Active Against Multi-Drug Resis
|
COOPER, MATTHEW
|
UNIVERSITY OF QUEENSLAND
|
AUSTRA
|
$323,937
|
Pneumonia
|
2014
|
NIAID
|
5F32AI108192-02
|
|
Elucidating the A. baumannii response to calprotectin-mediated zinc starvation
|
MORTENSEN, BRITTANY
|
VANDERBILT UNIVERSITY
|
TN
|
$53,282
|
Pneumonia
|
2014
|
NIAID
|
5F32AI102561-02
|
|
Evaluation of SARS-CoV 2'O Methyltransferase Mutants
|
MENACHERY, VINEET
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$55,094
|
Pneumonia
|
2014
|
NHLBI
|
4R00HL111151-03
|
|
The role of SP-A in Mp-induced exacerbations during allergic airway disease.
|
LEDFORD, JULIE
|
DUKE UNIVERSITY
|
NC
|
$249,000
|
Pneumonia
|
2014
|
NHLBI
|
268201100023C-6-0-1
|
|
LUNG TISSUE RESEARCH CONSORTIUM: TISSUE REPOSITORY
|
SULLIVAN, DIANE
|
NATIONAL JEWISH HEALTH
|
|
$934,015
|
Pneumonia
|
2014
|
NHLBI
|
268201100020C-7-0-1
|
|
TAS::75 0872::TAS LUNG TISSUE RESEARCH CONSORTIUM CLINICAL CENTER
|
LIMPER, ANDREW
|
MAYO CLINIC ROCHESTER
|
|
$574,089
|
Pneumonia
|
2014
|
NHLBI
|
268201100018C-6-0-1
|
|
TAS::75 0872:: TAS LUNG TISSUE RESEARCH CONSORTIUM: CLINICAL CENTER
|
MARTINEZ, FERNANDO
|
UNIVERSITY OF MICHIGAN
|
|
$797,164
|
Pneumonia
|
2014
|
NIAID
|
272200800006C-18-0-2
|
|
Vaccine and Treatment Evaluation Units
|
BERNSTIEN, DAVID
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
$123,745
|
Pneumonia
|
2014
|
NIAID
|
272200800004C-13-0-4
|
|
VACCINE AND TREATMENT EVALUATION UNITS
|
JACKSON, LISA
|
GROUP HEALTH COOPERATIVE
|
|
$379,243
|
Pneumonia
|
2014
|
NIAID
|
272201000047C-6-0-1
|
|
Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance
|
HOBERMAN, ALEHANDRO
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
$1,007,468
|
Pneumonia
|
2014
|
NIAID
|
3R01AI098775-03S1
|
|
RBD recombinant protein-based SARS vaccine for biodefense
|
HOTEZ, PETER
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$3,936
|
Pneumonia
|
2014
|
NIAID
|
4R33AI102197-03
|
|
NOX1 and NOX2 as Therapeutic Targets in Influenza
|
LAMBETH, JOHN
|
EMORY UNIVERSITY
|
GA
|
$468,000
|
Pneumonia
|
2014
|
NIEHS
|
1R56ES023566-01A1
|
|
Cluster Randomized Controlled Trial of an Advanced Stove to Reduce Risk of COPD
|
BALMES, JOHN
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$119,905
|
Pneumonia
|
2014
|
NIAID
|
3R01AI099107-03S1
|
|
Analysis of Coronavirus-Host Cell Interactions
|
MAKINO, SHINJI
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$30,327
|
Pneumonia
|
2014
|
NIAID
|
1R56AI104975-01A1
|
|
S. pneumoniae pilus regulation and host response
|
MALLEY, RICHARD
|
CHILDREN'S HOSPITAL CORPORATION
|
MA
|
$649,120
|
Pneumonia
|
2014
|
NIAID
|
2R56AI021548-29A1
|
|
PspA mechanisms of humoral immunity, functional assays, and optimal vaccine const
|
BRILES, DAVID
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$542,709
|
|
|